Reaction
Urge Incontinence reporting signals
As of the last recalculation, Urge Incontinence appears in 849 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is TOLTERODINE TARTRATE (PRR 47.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tolterodine Tartrate | 17 | 47.4 | 47.5 |
| Mirabegron | 47 | 31.5 | 31.5 |
| Fesoterodine Fumarate | 9 | 20.6 | 20.6 |
| Obinutuzumab | 12 | 18.1 | 18.1 |
| Baricitinib | 7 | 17.9 | 18.0 |
| Oxybutynin Chloride | 6 | 16.9 | 16.9 |
| Vibegron | 5 | 15.4 | 15.4 |
| Levodopa | 7 | 14.3 | 14.3 |
| Lacosamide | 16 | 10.7 | 10.7 |
| Trifluridine And Tipiracil | 3 | 6.9 | 6.9 |
| Alirocumab | 6 | 5.9 | 5.9 |